Sunday, September 3, 2023

Over 10,000 Sold!

This week, we passed a new milestone.  We have sold 10,000 copies of Beating the Dementia Monster!  Stacked one on top of another, that's a stack 1,500 feet high, or 0.28 miles if all were sold as paperback with the dimensions of the current edition.

That is both the first and second editions taken together, paperback and Kindle versions; English and Spanish editions.  Also, for a while the first edition was available through "Amazon Ultimate," where I only receive reports of page reads.  So I counted 200 page reads as one book sold.  And the first edition was a bit skinnier than the second edition and the Spanish edition.  So almost apples to apples, but not quite. 

When we started this project, I had no idea where it would lead.  Initial sales suggested I would get to 100 or so books and die there, but even that looked like an uphill slog.  I had some poor initial reviews that hurt sales.  Reviews are very important.  One negative review was from someone unhappy with the glue used to hold his book together, and another was from someone who simply didn't believe my story.  I don't know if either of them ever read the book.

But as time went on, the reviews got better, and sales rose.  I connected with some enthusiastic people in the medical field, and some in the Alzheimer's Association were supportive.  So the word got out.  Whenever a new group of people got excited about it, there would be a spike in sales.  I also engaged Brian Berni (in Italy) at Bookads.co, who is a real magician when it comes to working the Amazon algorithm. Today, we stand at 4.5 stars on Amazon from 270 ratings, which is just fine for a book like this.

If you are reading this blog post, you likely bought a copy of the book and may otherwise have contributed to the creation and popularity of the book.  So thank you very much!

No comments:

Post a Comment

Welcome Kisunla

We reported previously that the FDA's advisory panel had recommended approval of the monoclonal antibody treatment donanemab.  This foll...